2Foon RA, ZigheboimJ, Yale C,et al. Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia [J]. Blood, 1981;58 (5): 467-468
3Brito-Babapulle F, CatovskyD, slocombe G, et al. Phase Ⅱ study of mitoxantrone and cyarabine in elderly patients with acute myelogenous leukemia [J]. Blood, 1987, 26 (8):132-133
4Moody TW, FagarasanM, Zia F,et al.Thymosin alpha 1 down regulate the growth of human nonsmall cell lung cancer in vitro and in vivo [J].Cancer Res,1993;53(21): 5214-5218
5Garaci E, Pica F, Rasi G, et al.Thymosina in the treatment of cancer:, from basic research to clinical application[J].Int J Immunopharmaco1,2000;22(12): 1067-1076
6张之南.血液病学[M].北京:人民卫生出版社,2003.1101-1106.
7Foon R.A,Zigheboim J,Yale C.et al.Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia[J].Blood,1981,58(5):467-468.
8Brito-Babapulle F,Catovsky D,slocombe G,et al.Phase Ⅱ study of mitoxantrone and cyarabine in elderly patients with acute myelogenous leukemia[J].Blood,1987,26(8):132-133.
9Saito K. Low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor for the treatment of relapsed acute myeloid leukemia. Rinsho Ketsueki, 1996, 37:651-653.
10Bai A, Kojima H, Hori M, et al. Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells. Exp Hematol, 1999,27:259-265.
